Jared F Fradette (Jared J Fradette)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Advanced Non Small Cell Lung Cancer

Top Venues

Molecular cancer therapeutics

Molecular cancer research : MCR

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

B Leticia Rodriguez, Jiawei Huang, Laura Gibson, Jared F Fradette, Hung-I Harry Chen, Kikuye Koyano, Czrina Cortez, Betty Li, Carmence Ho, Amir M Ashique, Vicky Y Lin, Suzanne Crawley, Julie M Roda, Peirong Chen, Bin Fan, Jeong Kim, James Sissons, Jonathan Sitrin, Daniel D Kaplan, Don L Gibbons, Lee B Rivera
Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors. Molecular cancer therapeutics 23 (8) (2024)
B Leticia Rodriguez, Jiawei Huang, Laura Gibson, Jared F Fradette, Hung-I Harry Chen, Kikuye Koyano, Czrina Cortez, Betty Li, Carmence Ho, Amir M Ashique, Vicky Y Lin, Suzanne Crawley, Julie M Roda, Peirong Chen, Bin Fan, Jeong Kim, James Sissons, Jonathan Sitrin, Daniel D Kaplan, Don L Gibbons, Lee B Rivera
Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors. Molecular cancer therapeutics 23 (8) (2024)
B Leticia Rodriguez, Jiawei Huang, Laura Gibson, Jared F Fradette, Hung-I Harry Chen, Kikuye Koyano, Czrina Cortez, Betty Li, Carmence Ho, Amir M Ashique, Vicky Y Lin, Suzanne Crawley, Julie M Roda, Peirong Chen, Bin Fan, Jeong Kim, James Sissons, Jonathan Sitrin, Daniel D Kaplan, Don L Gibbons, Lee B Rivera
Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors. Molecular cancer therapeutics 23 (8) (2024)
B Leticia Rodriguez, Jiawei Huang, Laura Gibson, Jared F Fradette, Hung-I Harry Chen, Kikuye Koyano, Czrina Cortez, Betty Li, Carmence Ho, Amir M Ashique, Vicky Y Lin, Suzanne Crawley, Julie M Roda, Peirong Chen, Bin Fan, Jeong Kim, James Sissons, Jonathan Sitrin, Daniel D Kaplan, Don L Gibbons, Lee B Rivera
Anti-tumor activity of a novel LAIR1 antagonist in combination with anti-PD-1 to treat collagen-rich solid tumors. Molecular cancer therapeutics (2024)
B Leticia Rodriguez, Jiawei Huang, Laura Gibson, Jared F Fradette, Hung-I Harry Chen, Kikuye Koyano, Czrina Cortez, Betty Li, Carmence Ho, Amir M Ashique, Vicky Y Lin, Suzanne Crawley, Julie M Roda, Peirong Chen, Bin Fan, Jeong Kim, James Sissons, Jonathan Sitrin, Daniel D Kaplan, Don L Gibbons, Lee B Rivera
Anti-tumor activity of a novel LAIR1 antagonist in combination with anti-PD-1 to treat collagen-rich solid tumors. Molecular cancer therapeutics (2024)
B Leticia Rodriguez, Jiawei Huang, Laura Gibson, Jared F Fradette, Hung-I Harry Chen, Kikuye Koyano, Czrina Cortez, Betty Li, Carmence Ho, Amir M Ashique, Vicky Y Lin, Suzanne Crawley, Julie M Roda, Peirong Chen, Bin Fan, Jeong Kim, James Sissons, Jonathan Sitrin, Daniel D Kaplan, Don L Gibbons, Lee B Rivera
Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors. Molecular cancer therapeutics 23 (8) (2024)
Mabel Perez-Oquendo, Roxsan Manshouri, Yanhua Tian, Jared F Fradette, B Leticia Rodriguez, Samrat T Kundu, Don L Gibbons
ZEB1 is regulated by K811 acetylation to promote stability, NuRD complex interactions, EMT, and NSCLC metastasis. Molecular cancer research : MCR (2023)
Mabel Perez-Oquendo, Roxsan Manshouri, Yanhua Tian, Jared F Fradette, B Leticia Rodriguez, Samrat T Kundu, Don L Gibbons
ZEB1 is Regulated by K811 Acetylation to Promote Stability, NuRD Complex Interactions, EMT, and NSCLC Metastasis. Molecular cancer research : MCR (2023)
Rakhee Bajaj, Amanda N Warner, Jared F Fradette, Don L Gibbons
Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis. Cells 11 (9) (2022)
David H Peng, B Leticia Rodriguez, Lixia Diao, Pierre-Olivier Gaudreau, Aparna Padhye, Jessica M Konen, Joshua Kapere Ochieng, Caleb A Class, Jared F Fradette, Laura Gibson, Limo Chen, Jing Wang, Lauren Averett Byers, Don L Gibbons
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers. Nature communications 12 (1) (2021)
Jessica M Konen, B Leticia Rodriguez, Aparna Padhye, Joshua K Ochieng, Laura Gibson, Lixia Diao, Natalie Wall Fowlkes, Jared F Fradette, David H Peng, Robert J Cardnell, Jeffrey J Kovacs, Jing Wang, Lauren Averett Byers, Don L Gibbons
Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC. Cancer research 81 (5) (2021)
Joshua Kapere Ochieng, Samrat T Kundu, Rakhee Bajaj, B Leticia Rodriguez, Jared F Fradette, Don L Gibbons
MBIP (MAP3K12 binding inhibitory protein) drives NSCLC metastasis by JNK-dependent activation of MMPs. Oncogene 39 (43) (2020)
Rakhee Bajaj, Samrat T Kundu, Caitlin L Grzeskowiak, Jared F Fradette, Kenneth L Scott, Chad J Creighton, Don L Gibbons
IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion. Oncogene 39 (37) (2020)
David H Peng, Samrat T Kundu, Jared F Fradette, Lixia Diao, Pan Tong, Lauren A Byers, Jing Wang, Jaime Rodriguez Canales, Pamela A Villalobos, Barbara Mino, Yanan Yang, Rosalba Minelli, Michael D Peoples, Christopher A Bristow, Timothy P Heffernan, Alessandro Carugo, Ignacio I Wistuba, Don L Gibbons
ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism. Science translational medicine 11 (483) (2020)
Jose A Monteiro de Oliveira Novaes, Taghreed Hirz, Irene Guijarro, Monique Nilsson, Marlese A Pisegna, Alissa Poteete, Hampartsoum B Barsoumian, Jared F Fradette, Limo N Chen, Don L Gibbons, Xiangjun Tian, Jing Wang, Jeffrey N Myers, Mark J McArthur, Diana Bell, William N William, John Victor Heymach
Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma. Cancer prevention research (Philadelphia, Pa.) 14 (3) (2020)